Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters - PubMed (original) (raw)
Multicenter Study
. 1998 Mar 1;58(5):1004-12.
A Borg, M Cuny, D N Crichton, T Baldersson, T I Andersen, M A Caligo, R Lidereau, A Lindblom, S Seitz, D Kelsell, U Hamann, P Rio, S Thorlacius, J Papp, E Olah, B Ponder, Y J Bignon, S Scherneck, R Barkardottir, A L Borresen-Dale, J Eyfjörd, C Theillet, A M Thompson, C Larsson, et al.
Affiliations
- PMID: 9500463
Multicenter Study
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters
C M Phelan et al. Cancer Res. 1998.
Abstract
The pattern of loss of heterozygosity (LOH) on chromosome 17 in human breast cancer is complicated and shows many different regions of loss. In an attempt to narrow down the relevant regions of LOH on chromosome 17, we have studied the deletion pattern and its association with clinical parameters in 1280 breast carcinoma-venous blood lymphocyte pairs. In total, 42 different chromosome 17 loci were investigated, and between 25 and 625 cases were analyzed at each locus. The frequency of LOH observed on the p arm was much higher than that observed on the q arm. The opposite effect was observed in 52 ovarian cancer cases investigated, with less LOH on 17p than on 17q. Patterns of loss consistent with interstitial and terminal deletions, as well as loss of either the p or q arm or monosomy 17 were observed. To determine whether loss at particular loci may be associated with biological features of breast tumors, clinical data including age of onset, family history of breast cancer, tumor histopathology, tumor size, estrogen receptor (ER) status, and occurrence of lymph node or distant metastases were collected for each case. Overall, large-sized, ER-negative, lymph node-positive ductal tumors showed the highest frequencies of LOH, with ER-negative and ductal tumors showing LOH for markers along the majority of the chromosome. Eight regions of chromosome 17 appear to be associated with human breast cancer, two on 17p and six on 17q. These regions were not necessarily in the areas exhibiting the highest frequencies of LOH but were defined by interstitial and terminal deletions in multiple independent cases. Seven of these regions showed statistically significant differences in LOH associated with clinical parameters. These data strongly suggest that loci on chromosome 17 may determine aspects of tumor presentation and disease behavior in human breast cancer and pinpoint candidate tumor suppressor gene loci.
Similar articles
- Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
Lindblom A, Rotstein S, Skoog L, Nordenskjöld M, Larsson C. Lindblom A, et al. Cancer Res. 1993 Aug 15;53(16):3707-11. Cancer Res. 1993. PMID: 8339280 - Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.
Radford DM, Fair KL, Phillips NJ, Ritter JH, Steinbrueck T, Holt MS, Donis-Keller H. Radford DM, et al. Cancer Res. 1995 Aug 1;55(15):3399-405. Cancer Res. 1995. PMID: 7614479 - Deletion of the short arm of chromosome 3 in breast tumors.
Pandis N, Bardi G, Mitelman F, Heim S. Pandis N, et al. Genes Chromosomes Cancer. 1997 Apr;18(4):241-5. Genes Chromosomes Cancer. 1997. PMID: 9087563 Review. - [Loss of heterozygosity in the progression of tumors].
Sasaki MS, Toguchida J. Sasaki MS, et al. Gan To Kagaku Ryoho. 1989 Oct;16(10):3347-53. Gan To Kagaku Ryoho. 1989. PMID: 2679392 Review. Japanese.
Cited by
- [High expression of ZNF652 promotes carcinogenesis and progression of breast cancer].
Lei T, Xiao B, He Y, Sun Z, Li L. Lei T, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2020 Dec 30;40(12):1732-1739. doi: 10.12122/j.issn.1673-4254.2020.12.06. Nan Fang Yi Ke Da Xue Xue Bao. 2020. PMID: 33380394 Free PMC article. Chinese. - Novel role of BRCA1 interacting C-terminal helicase 1 (BRIP1) in breast tumour cell invasion.
Rizeq B, Sif S, Nasrallah GK, Ouhtit A. Rizeq B, et al. J Cell Mol Med. 2020 Oct;24(19):11477-11488. doi: 10.1111/jcmm.15761. Epub 2020 Sep 5. J Cell Mol Med. 2020. PMID: 32888398 Free PMC article. - The ubiquitin-proteasome system and chromosome 17 in cerebellar granule cells and medulloblastoma subgroups.
Vriend J, Marzban H. Vriend J, et al. Cell Mol Life Sci. 2017 Feb;74(3):449-467. doi: 10.1007/s00018-016-2354-3. Epub 2016 Sep 3. Cell Mol Life Sci. 2017. PMID: 27592301 Free PMC article. Review. - -148 C/T polymorphism of Axin2 contributes to a decreased risk of cancer: evidence from a meta-analysis.
Zhong A, Pan X, Shi M, Xu H. Zhong A, et al. Onco Targets Ther. 2015 Jul 29;8:1957-66. doi: 10.2147/OTT.S86738. eCollection 2015. Onco Targets Ther. 2015. PMID: 26251618 Free PMC article. - Clinical Implications of Rabphillin-3A-Like Gene Alterations in Breast Cancer.
Putcha BD, Jia X, Katkoori VR, Salih C, Shanmugam C, Jadhav T, Bovell LC, Behring MP, Callens T, Messiaen L, Bae S, Grizzle WE, Singh KP, Manne U. Putcha BD, et al. PLoS One. 2015 Jun 12;10(6):e0129216. doi: 10.1371/journal.pone.0129216. eCollection 2015. PLoS One. 2015. PMID: 26070152 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical